Linders, Annet Nicole http://orcid.org/0000-0003-0912-1434
Dias, Itamar Braga
López Fernández, Teresa http://orcid.org/0000-0002-3414-7022
Tocchetti, Carlo Gabriele
Bomer, Nils http://orcid.org/0000-0001-5926-6960
Van der Meer, Peter http://orcid.org/0000-0002-9705-4413
Article History
Received: 30 August 2023
Accepted: 2 January 2024
First Online: 23 January 2024
Competing interests
: The University Medical Center Groningen, which employs several of the authors, has received research grants and/or fees from AstraZeneca, Vifor Pharma, Pharmacosmos, Pharma Nord, Ionis, Abbott, Bristol Myers Squibb, Novartis, Novo Nordisk, and Roche. P.v.d.M. has received consultancy fees and/or grants from Novartis, Pharmacosmos, Vifor Pharma, AstraZeneca, Pfizer, Pharma Nord, BridgeBio, Novo Nordisk, and Ionis, all paid to the institution. C.G.T. reports honoraria or consultation fees from VivaLyfe, Univers Formazione, Solaris, Summeet, Astra Zeneca, Myocardial Solutions; funding from Amgen and MSD; listed as an inventor of two patents related to HF, outside the submitted work. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.